Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune activation in chronic heart failure.

Guillermo Torre-Amione1

  • 1Heart Transplant Service, Methodist DeBakey Heart Center, Baylor College of Medicine, Houston, Texas 77030, USA. gtorre@bcm.tmc.edu

The American Journal of Cardiology
|June 1, 2005
PubMed
Summary

Chronic heart failure (CHF) involves immune system activation, leading to inflammation. Therapies enhancing the natural anti-inflammatory response, like IVIG, show promise over targeting single cytokines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of longitudinal studies to overcome global Hispanic/Latino underrepresentation in clinical research: a need for collaborative efforts.

Lancet regional health. Americas·2026
Same author

Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: primary results of the ARCHER study.

ESC heart failure·2026
Same author

Rationale and design of the REMECHOQUE multicentre registry protocol: evaluating therapeutic trends in cardiogenic shock.

BMJ open·2026
Same author

Hospital Zambrano Hellion pulmonary embolism response team: PERT-PREVENTION.

Archivos de cardiologia de Mexico·2025
Same author

Mitochondrial Ca<sup>2+</sup> overload is a pivotal risk factor for lethal ventricular arrhythmias due to the oxidation of mitochondrial respirasome and energetic failure.

British journal of pharmacology·2025
Same author

oriGen cohort: a Mexican population-based epidemiological and genomic research platform.

Journal of epidemiology and community health·2025

Area of Science:

  • Immunology
  • Cardiology
  • Systemic Inflammation

Background:

  • Chronic heart failure (CHF) involves immune system activation, including proinflammatory cytokine release and autoantibody production.
  • CHF should be viewed as a systemic illness, not solely a cardiac pump dysfunction.
  • Immune activation in CHF stems from direct antigenic stimulation or cardiac injury exposing neoantigens.

Purpose of the Study:

  • To explore the role of immune system activation in chronic heart failure.
  • To evaluate the effectiveness of different therapeutic approaches for immune modulation in CHF.

Main Methods:

  • Analysis of immune system components in CHF patients, including cytokines like tumor necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1), and IL-6.
  • Review of therapeutic strategies such as intravenous immunoglobulin (IVIG), immunoadsorption, and immune-modulation therapy (IMT).

Main Results:

  • Elevated levels of proinflammatory cytokines (TNF-alpha, IL-1, IL-6) are observed in CHF patients.
  • Direct targeting of single cytokines has shown limited success due to immune system redundancy.
  • Therapies that enhance the natural anti-inflammatory response demonstrate potential clinical benefit.

Conclusions:

  • Immune activation is a critical component of CHF pathophysiology.
  • Enhancing the body's natural anti-inflammatory mechanisms offers a promising therapeutic avenue for CHF.
  • Further research is needed to elucidate the precise mechanisms of immunomodulatory therapies like IVIG.

Related Experiment Videos